Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
NRX Pharmaceuticals (NRXP) has shared an update.
NRx Pharmaceuticals, Inc. shareholders have greenlit a potential reverse stock split, empowering the Board to decide if and when to consolidate shares at a ratio between 1-for-2 and 1-for-15 before the next annual milestone. This strategic move, aimed at potentially enhancing stock value and marketability, was announced following a special meeting, with the majority of votes supporting the amendment. The company publicly shared the voting outcome and emphasized that no other issues were on the ballot.
Learn more about NRXP stock on TipRanks’ Stock Analysis page.